126 related articles for article (PubMed ID: 38290167)
1. Impact of Lung Cancer on Health-Related Quality of Life, Financial Toxicity, and Household Economics in Patients From the Public and the Private Healthcare Sector in Argentina.
Augustovski F; Tsou F; González L; Martín C; Vigo S; Gabay C; Alcaraz A; Argento F
Value Health Reg Issues; 2024 May; 41():94-99. PubMed ID: 38290167
[TBL] [Abstract][Full Text] [Related]
2. The association of financial difficulties and out-of-pocket payments with health-related quality of life among breast, prostate and colorectal cancer patients.
Koskinen JP; Färkkilä N; Sintonen H; Saarto T; Taari K; Roine RP
Acta Oncol; 2019 Jul; 58(7):1062-1068. PubMed ID: 30943813
[No Abstract] [Full Text] [Related]
3. Household utilization and expenditure on private and public health services in Vietnam.
Ha NT; Berman P; Larsen U
Health Policy Plan; 2002 Mar; 17(1):61-70. PubMed ID: 11861587
[TBL] [Abstract][Full Text] [Related]
4. Out-of-pocket expenses for maternity care in rural Bangladesh: a public-private comparison.
Rahman M; Rob U; Noor FR; Bellows B
Int Q Community Health Educ; 2012-2013; 33(2):143-57. PubMed ID: 23661416
[TBL] [Abstract][Full Text] [Related]
5. Financial toxicity and its associations with health-related quality of life among urologic cancer patients in an upper middle-income country.
Ting CY; Teh GC; Yu KL; Alias H; Tan HM; Wong LP
Support Care Cancer; 2020 Apr; 28(4):1703-1715. PubMed ID: 31292755
[TBL] [Abstract][Full Text] [Related]
6. How Business Cycles Affect the Healthcare Sector: A Cross-country Investigation.
Cleeren K; Lamey L; Meyer JH; De Ruyter K
Health Econ; 2016 Jul; 25(7):787-800. PubMed ID: 25916435
[TBL] [Abstract][Full Text] [Related]
7. Cost burden associated with advanced non-small cell lung cancer in Europe and influence of disease stage.
Wood R; Taylor-Stokes G
BMC Cancer; 2019 Mar; 19(1):214. PubMed ID: 30849964
[TBL] [Abstract][Full Text] [Related]
8. Quantifying the economic impact of government and charity funding of medical research on private research and development funding in the United Kingdom.
Sussex J; Feng Y; Mestre-Ferrandiz J; Pistollato M; Hafner M; Burridge P; Grant J
BMC Med; 2016 Feb; 14():32. PubMed ID: 26908129
[TBL] [Abstract][Full Text] [Related]
9. The patient-level effect of the cost of Cancer care - financial burden in German Cancer patients.
Mehlis K; Witte J; Surmann B; Kudlich M; Apostolidis L; Walther J; Jäger D; Greiner W; Winkler EC
BMC Cancer; 2020 Jun; 20(1):529. PubMed ID: 32503459
[TBL] [Abstract][Full Text] [Related]
10. Assessing the Relationship between Socio-demographic, Clinical Profile and Financial Toxicity: Evidence from Cancer Survivors in Sarawak.
Yap SL; Wong SS; Chew KS; Kueh JS; Siew KL
Asian Pac J Cancer Prev; 2020 Oct; 21(10):3077-3083. PubMed ID: 33112570
[TBL] [Abstract][Full Text] [Related]
11. High use of private providers for first healthcare seeking by drug-resistant tuberculosis patients: a cross-sectional study in Yangon, Myanmar.
Sidharta SD; Yin JD; Yoong JS; Khan MS
BMC Health Serv Res; 2018 Apr; 18(1):276. PubMed ID: 29642905
[TBL] [Abstract][Full Text] [Related]
12. The humanistic burden of advanced non-small cell lung cancer (NSCLC) in Europe: a real-world survey linking patient clinical factors to patient and caregiver burden.
Wood R; Taylor-Stokes G; Smith F; Chaib C
Qual Life Res; 2019 Jul; 28(7):1849-1861. PubMed ID: 30825160
[TBL] [Abstract][Full Text] [Related]
13. Do patients with haematological malignancies suffer financial burden? A cross-sectional study of patients seeking care through a publicly funded healthcare system.
Parker C; Ayton D; Zomer E; Liew D; Vassili C; Fong CY; Wei A
Leuk Res; 2022 Jan; 112():106748. PubMed ID: 34798569
[TBL] [Abstract][Full Text] [Related]
14. Financial Toxicity After Cancer in a Setting With Universal Health Coverage: A Call for Urgent Action.
Bhoo-Pathy N; Ng CW; Lim GC; Tamin NSI; Sullivan R; Bhoo-Pathy NT; Abdullah MM; Kimman M; Subramaniam S; Saad M; Taib NA; Chang KM; Goh PP; Yip CH
J Oncol Pract; 2019 Jun; 15(6):e537-e546. PubMed ID: 31112479
[TBL] [Abstract][Full Text] [Related]
15. Health insurance status and outcomes of critically ill obstetric patients: a prospective cohort study in Argentina.
Vasquez DN; Das Neves AV; Aphalo VB; Loudet CI; Roberti J; Cicora F; Casanova M; Canales HS; Intile AD; Scapellato JL; Desmery PM; Estenssoro E
J Crit Care; 2014 Apr; 29(2):199-203. PubMed ID: 24360595
[TBL] [Abstract][Full Text] [Related]
16. Cost of injury care in India: cross-sectional analysis of National Sample Survey 2014.
Tripathy JP; Jagnoor J; Prasad BM; Ivers R
Inj Prev; 2018 Apr; 24(2):116-122. PubMed ID: 28724552
[TBL] [Abstract][Full Text] [Related]
17. Hong Kong domestic health spending: financial years 1989/90 to 2008/09.
Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Chui AW; Lo SV
Hong Kong Med J; 2012 Aug; 18(4 Suppl 4):1-23. PubMed ID: 22947491
[TBL] [Abstract][Full Text] [Related]
18. The determinants of the public-private mix in Canadian health care expenditures: 1975-1996.
Di Matteo L
Health Policy; 2000 Jun; 52(2):87-112. PubMed ID: 10794839
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life in HIV/AIDS patients on antiretroviral therapy at a tertiary care facility in Zimbabwe.
Mafirakureva N; Dzingirai B; Postma MJ; van Hulst M; Khoza S
AIDS Care; 2016 Jul; 28(7):904-12. PubMed ID: 27098289
[TBL] [Abstract][Full Text] [Related]
20. The Economic Impact on Australian Patients with Neuroendocrine Tumours.
Gordon LG; Elliott TM; Wakelin K; Leyden S; Leyden J; Michael M; Pavlakis N; Mumford J; Segelov E; Wyld DK
Patient; 2020 Jun; 13(3):363-373. PubMed ID: 32072460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]